---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002010"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:30:53.250462+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics appoints Robert Gagnon to board of directors, replacing Erick Lucera

## Summary
- Robert Gagnon appointed to board effective Jan 8, 2024; Erick Lucera resigned same date.
- Gagnon will chair audit committee and serve on compensation and nominating committees.
- He brings 20+ years finance experience; currently CFO of Remix Therapeutics.
- Board size remains at four members after appointment.

## SEC filing metadata
- accession: 0001493152-24-002010
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002010
- JSON: https://secwatch.observer/filing/0001493152-24-002010.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002010.txt

## Key facts
- Executive change
  Robert E. Gagnon was appointed as Director at Bone Biologics Corp.
  - Action: appointed
  - Role: Director
  source text: On January 8, 2024, the Board of Directors of Bone Biologics Corporation (the “Company”) appointed Robert E. Gagnon to the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm
- Executive change
  Erick Lucera resigned as Director at Bone Biologics Corp.
  - Action: resigned
  - Role: Director
  source text: As previously disclosed, Erick Lucera resigned from the Board of Directors on December 27, 2023, effective as of the date Mr. Gagnon was appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.